A study looking at pembrolizumab for triple negative breast cancer (KEYNOTE-119)

Please note

This trial is no longer recruiting patients. We hope to add results when they are available.

Overview

Cancer types:

Breast cancer

Status:

Closed

Phase:

Phase 3

Details

This study is for people with triple negative breast cancer that has spread elsewhere in the body. They must have already had 1 or 2 treatments since the cancer spread.

Triple negative breast cancers are cancers that don’t have for oestrogen, progesterone or Her2. When it has spread to another part of the body it is called metastatic triple negative breast cancer.

Recruitment start: 9 March 2016

Recruitment end: 31 March 2017